Rigel Pharmaceuticals (RIGL) Interest Coverage Ratio (2010 - 2026)

Rigel Pharmaceuticals' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 8.29 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 20.32% year-over-year to 8.29; the TTM figure through Mar 2026 stood at 18.05 (up 224.55% YoY), while the FY2025 annual figure was 17.14, up 460.99% from the prior year.
• Interest Coverage Ratio was 8.29 for Q1 2026 at Rigel Pharmaceuticals, down from 13.64 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 32.61 in Q2 2025 to a low of 22.79 in Q2 2022.
• Historically, Interest Coverage Ratio has averaged 0.5 across 5 years, with a median of 1.03 in 2023.
• The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio tumbled 207.17% in 2022, then surged 14700.2% in 2025.
• A 5-year view of Interest Coverage Ratio shows it stood at 1.88 in 2022, then slumped by 45.11% to 1.03 in 2023, then jumped by 726.35% to 8.52 in 2024, then jumped by 60.08% to 13.64 in 2025, then sank by 39.18% to 8.29 in 2026.
• The last three Interest Coverage Ratio figures came in at 8.29 (Q1 2026), 13.64 (Q4 2025), and 15.01 (Q3 2025), per Business Quant data.